Gender-dependent specific immune response during chronic human Schistosomiasis haematobia

Clinical and Experimental Immunology

Volumn 124, Issue 1, 2001, Pages 62-68

  Remoué, Franck ^a   To Van, D ^b   Schacht, A M ^a   Picquet, M ^c   Garraud, O ^d   Vercruysse, J ^c   Ly, A ^b   Capron, A ^a   Riveau, G ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b Programme ESPOIR   (Senegal)

^c GHENT UNIVERSITY   (Belgium)

^d INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

Antibodies and cytokines; Gender; Helminths infection; Human; Infectious immunity parasites

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MATRIX PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SENEGAL; SEX DIFFERENCE; TH1 CELL;

ADULT; AGED; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ANTIGENS, NUCLEAR; APOPTOSIS; CHRONIC DISEASE; FEMALE; GLUTATHIONE TRANSFERASE; HELMINTH PROTEINS; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN A; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; PARASITE EGG COUNT; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SENEGAL; SEX CHARACTERISTICS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034998142     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01495.x     Document Type: Article

References (34)

1. 1 Dunne DW, Hagan P, Abath FGC. Prospects for immunological control of schistosomiasis. Lancet 1995; 345:1488-92.
2. 2 Couissinier-Paris P, Dessein AJ. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are TH0/2. Eur J Immunol 1995; 25:2295-302.
3. 3 Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth Schistosoma mansoni. J Exp Med 1991; 173:159-66.
4. 4 Capron A. Schistosomiasis: forty years' war on the worm. Parasitol Today 1998; 14:379-84.
5. 5 Montenegro SML, Miranda P, Mahanty S et al. Cytokine production in acute versus chronic human Schistosomiasis mansoni: the cross-regulatory role of interferon-γ and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens. J Infect Dis 1999; 179:1502-8.
6. 6 Balloul JM, Sondermeyer P, Dreyer D et al. Molecular cloning of a protective antigen of schistosomes. Nature 1987; 326:149-53.
7. 7 Auriault C, Gras-Masse H, Pierce RJ et al. Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 Glutathione-S-Transferase and to synthetic peptides. J Clin Microbiol 1990; 28:1918-24.
8. 8 Grzych JM, Grezel D, Xu CB et al. IgA antibodies to a protective antigen in human schistosomiasis mansoni. J Immunol 1993; 150:527-35.
9. 9 Gryseels B. Human resistance to Schistosoma infections: age or experience? Parasitol Today 1994; 10:380-5.
10. 10 Fulford AJC, Webster M, Ouma JH, Kimani G, Dunne DW. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol Today 1998; 14:23-9.
11. 11 Webster M, Libranda-Ramirez BDL, Aligui GD et al. The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines. Parasitology 1997; 114:383-93.
12. 12 Remoué F, Rogerie F, Gallissot MC et al. Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human population. J Infect Dis 2000; 181:1855-9.
13. 13 Shaw DI, Vercruysse J, Picquet M, Sambou B, Ly A. The effect of different treatment regimens on the epidemiology of seasonally transmitted Schistosoma haematobium infections in four villages in the Senegal River Basin. Senegal Trans Roy Soc Trop Med 1999; 93:1-9.
14. 14 Deelder AM, Qian ZL, Kremsner PG et al. Quantitative diagnosis of Schistosoma infections by measurements of circulating antigens in serum and urine. Trop Geo Med 1994; 46:233-8.
15. 15 Miller TE, Beausang LA, Meneghini M, Lidgard G. Cell death and nuclear matrix proteins. In: Apoptosis II The Molecular Basis of Apoptosis in Disease. Coldspring Harbor: Coldspring Harbor Laboratory Press, 1994: 357-76.
16. 16 Baize S, Leroy EM, Georges-Courbot MC et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nature Med 1999; 5:423.
17. 17 Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR. Immuno-suppressive effects of apoptotic cells. Nature 1997; 390:350-1.
18. 18 Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Hensin PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998; 101:890-8.
19. 19 Chantry D, Turner M, Abney E, Feldman M. Modulation of cytokine production by transforming growth factor-β. J Immunol 1989; 142:4295-300.
20. 20 De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
21. 21 Defrance T, Vanbervliet B, Brière F, Durand I, Rousset F, Banchereau J. Interleukin 10 and Transforming Growth Factor β cooperate to induce anti-CD40-activated naive human B cells to secrete Immunoglobulin A. J Exp Med 1992; 175:671-82.
22. 22 Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994; 265:1237-40.
23. 23 Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SI, Weiner HL, Hafler DA. Induction of circulating Myelin Basic Protein and Proteolipid Protein-specific transforming growth factor-β1 -secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996; 98:70-7.
24. 24 Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18:335-43.
25. 25 Ruegemer JJ, Ho SN, Augustine JA et al. Regulatory effects of transforming growth factor-β on IL-2- and IL-4-dependent T cell-cycle progression. J Immunol 1990; 144:1767-76.
26. 26 De Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-26.
27. 27 Atkins NS, Lindo JF, Lee MG et al. Humoral responses in human strongyloidiasis: correlations with infection chronicity. Trans Roy Soc Trop Med Hyg 1997; 91:609-13.
28. 28 Doetze A, Satoguina J, Burchard G et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokines IL-10 and transforming growth factor-β but not by a Th1 to Th2 shift. Intern Immunol 2000; 12:623-30.
29. 29 Schuurs AHWM, Verheul HAM. Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990; 35:157-72.
30. 30 Gomez E, Ortiz V, Saint-Martin B, Boeck L, Diaz-Sanchez V, Bourges H. Hormonal regulation of the secretory IgA (sIgA) system: estradiol-and progesterone-induced changes in sIgA in parotid saliva along the menstrual cycle. Am J Reprod Immunol 1993; 29:219-23.
31. 31 Ashroft GS, Dodsworth J, van Boxtel E et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nature Med 1997; 3:1209-15.
32. 32 Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from Multiple Sclerosis patients and normal control subjects. J Immunol 1997; 158:446-51.
33. 33 Piccini MP, Giudizi MG, Biagiotti R et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155:128-33.
34. 34 Tsukamoto A, Kaneko Y, Yoshida T, Han K, Ichinose M, Kimura S. 2-methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and β-galactosidase expression in vascular endothelial cells. Biochem Biophys Res Commun 1998; 248:9-12.